IMPROVEMENT IN TREATMENT SATISFACTION AMONG PRIMARY IMMUNODEFICIENCY PATIENTS ON AN INVESTIGATIONAL 20 % SUBCUTANEOUS IMMUNOGLOBULIN THERAPY

被引：0
|
作者：
Meckley, Lisa [1 ]
Ito, Diane [1 ]
Hu, Xingdi [1 ]
Yel, Leman [2 ]
机构：
[1] Baxalta US Inc, HEOR, Cambridge, MA USA
[2] Baxalta US Inc, Immunol, Clin Sci, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2016年 / 36卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
4335
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [1] IMPROVEMENT IN TREATMENT SATISFACTION AMONG PATIENTS WITH PIDD ON AN INVESTIGATIONAL 20% SUBCUTANEOUS IMMUNOGLOBULIN THERAPY
    Meckley, L.
    Ito, D.
    Hu, X.
    Yel, L.
    Kauf, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S99 - S99
  • [2] TREATMENT PREFERENCE AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) ON INVESTIGATIONAL 20% SUBCUTANEOUS IMMUNOGLOBULIN THERAPY
    Berner, T.
    Meckley, L.
    Yel, L.
    Engl, W.
    Ito, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S98 - S99
  • [3] Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy
    Krishnarajah, Girishanthy
    Lehmann, Jee-Yeon K.
    Ellman, Brian
    Bhak, Rachel H.
    DerSarkissian, Maral
    Leader, Deane, Jr.
    Bullinger, Ann L.
    Duh, Mei Sheng
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (15): : S475 - S481
  • [4] INITIATION OF 20% SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY NAIVE TO IG THERAPY
    Duff, Carla
    Leiding, Jennifer W.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 208 - 208
  • [5] Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
    Skoda-Smith, Suzanne
    Torgerson, Troy R.
    Ochs, Hans D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 1 - 10
  • [6] Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies
    Mallick, Rajiv
    Jolles, Stephen
    Kanegane, Hirokazu
    Agbor-Tarh, Dominique
    Rojavin, Mikhail
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (08) : 886 - 897
  • [7] Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies
    Rajiv Mallick
    Stephen Jolles
    Hirokazu Kanegane
    Dominique Agbor-Tarh
    Mikhail Rojavin
    Journal of Clinical Immunology, 2018, 38 : 886 - 897
  • [8] Effectiveness, Safety, and Treatment Satisfaction of 20% Subcutaneous Immunoglobulin Replacement Therapy in Pediatric Patients with Primary and Secondary Immunodeficiencies
    Yildiz, Ceren Ayca
    Gokdemir, Yasemin
    Eralp, Ela Erdem
    Ergenekon, Pinar
    Karakoc, Fazilet
    Karadag, Bulent
    TURKISH ARCHIVES OF PEDIATRICS, 2025, 60 (02):
  • [9] Safety, efficiency, and treatment satisfaction in children with primary immunodeficiency receiving subcutaneous immunoglobulin treatment
    Eltan, Sevgi Bilgic
    Keskin, Ozlem
    Deveci, Mehmet Fatih
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (03) : 228 - 234
  • [10] 20% subcutaneous immunoglobulin for patients with primary immunodeficiency diseases: A systematic review
    Song, Jie
    Zhang, Lingli
    Li, Youping
    Quan, Shuyan
    Liang, Yi
    Zeng, Linan
    Liu, Yi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 25 (02) : 457 - 464
12345